OR

356.35

+1.77%↑

B.US

42.21

+6.97%↑

ASM

670

+5.21%↑

IAG.ES

4.24

+5.21%↑

UPM.FI

27.06

+0.97%↑

OR

356.35

+1.77%↑

B.US

42.21

+6.97%↑

ASM

670

+5.21%↑

IAG.ES

4.24

+5.21%↑

UPM.FI

27.06

+0.97%↑

OR

356.35

+1.77%↑

B.US

42.21

+6.97%↑

ASM

670

+5.21%↑

IAG.ES

4.24

+5.21%↑

UPM.FI

27.06

+0.97%↑

OR

356.35

+1.77%↑

B.US

42.21

+6.97%↑

ASM

670

+5.21%↑

IAG.ES

4.24

+5.21%↑

UPM.FI

27.06

+0.97%↑

OR

356.35

+1.77%↑

B.US

42.21

+6.97%↑

ASM

670

+5.21%↑

IAG.ES

4.24

+5.21%↑

UPM.FI

27.06

+0.97%↑

Search

Tessenderlo Group SA

Затворен

СекторБазови материали

20.55 4.85

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

19.6

Максимум

20.55

Ключови измерители

By Trading Economics

Приходи

-9.5M

Продажби

1.5B

EPS

-0.16

Дивидентна доходност

3.62

Марж на печалбата

-0.639

Служители

7,000

EBITDA

162M

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

3.62%

2.88%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

1.2B

Предишно отваряне

15.7

Предишно затваряне

20.55

Настроения в новините

By Acuity

50%

50%

74 / 150 Класиране в Basic materials

Tessenderlo Group SA Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

31.03.2026 г., 23:31 ч. UTC

Горещи акции

Stocks to Watch: Nike, RH, NCino

31.03.2026 г., 22:35 ч. UTC

Печалби

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1.04.2026 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31.03.2026 г., 23:50 ч. UTC

Придобивния, сливания и поглъщания

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31.03.2026 г., 23:43 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31.03.2026 г., 23:33 ч. UTC

Пазарно говорене
Значими събития в новините

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31.03.2026 г., 23:21 ч. UTC

Печалби

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31.03.2026 г., 23:14 ч. UTC

Пазарно говорене
Печалби

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31.03.2026 г., 23:12 ч. UTC

Пазарно говорене

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31.03.2026 г., 22:36 ч. UTC

Печалби

China Vanke 2025 Loss Widens >000002.SZ

31.03.2026 г., 22:36 ч. UTC

Печалби

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31.03.2026 г., 22:36 ч. UTC

Печалби

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31.03.2026 г., 22:36 ч. UTC

Печалби

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31.03.2026 г., 22:36 ч. UTC

Печалби

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31.03.2026 г., 21:46 ч. UTC

Придобивния, сливания и поглъщания

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31.03.2026 г., 21:36 ч. UTC

Пазарно говорене

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31.03.2026 г., 21:35 ч. UTC

Печалби

Nike Expects China Sales Down 20% in 4Q, CFO Says

31.03.2026 г., 21:35 ч. UTC

Печалби

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31.03.2026 г., 21:35 ч. UTC

Печалби

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31.03.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31.03.2026 г., 21:33 ч. UTC

Печалби

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31.03.2026 г., 21:32 ч. UTC

Печалби

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31.03.2026 г., 21:28 ч. UTC

Печалби

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31.03.2026 г., 21:26 ч. UTC

Печалби

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31.03.2026 г., 21:25 ч. UTC

Печалби

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31.03.2026 г., 21:24 ч. UTC

Пазарно говорене
Печалби

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31.03.2026 г., 21:22 ч. UTC

Печалби

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31.03.2026 г., 21:22 ч. UTC

Печалби

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31.03.2026 г., 21:21 ч. UTC

Печалби

Nike's Digital Channel Still Too Promotional, CFO Says

31.03.2026 г., 21:20 ч. UTC

Печалби

Nike CEO: Converse Remains Important to Portfolio

Сравнение с други в отрасъла

Ценова промяна

Tessenderlo Group SA Прогноза

Настроение

By Acuity

74 / 150 Класиране в Базови материали

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Tessenderlo Group SA

Tessenderlo Group NV, together with its subsidiaries, engages in the agriculture, valorizing bio-residuals, energy, and industrial solution businesses worldwide. It operates through five segments: Agro, Bio-Valorization, Industrial Solutions, Machines & Technologies, and T-Power. The Agro segment engages in the production, marketing, and trading of crop nutrients, including liquid crop and potassium sulfate fertilizers, and organic soil improvers, as well as organic and non-organic crop protection products. This segment offers its specialty fertilizers under Thio-Sul, KTS, K-Row 23, CaTs, GranuPotasse, SoluKem, SoluPotasse, and MAJOR 90 brands. The Bio-Valorization segment produces, sells, and trades in gelatins and collagen peptides, and proteins and fats. The Industrial Solutions segment is involved in the provision of preassembled piping kits, project consultancy services, engineering support for ventilation solutions, sewage and rainwater solutions, and siphonic roof drainage systems; coagulants and other chemicals for the treatment of wastewater, and the purification of drinking water; production and sale of industrial chemicals, such as bleach, sulfuric acid, sodium hydroxide, various grades of hydrochloric acid, and calcium chloride, as well as sulfur chemicals. The Machines & Technologies segment engages in the design, development, production, sale, support, and service of weaving machines, as well as related upgrade kits and spare parts, and training and repair services; engineered casting solutions, and drill tips and anchor solutions; customized controller systems; and precision parts. The T-Power segment produces electricity through a combined cycle gas turbine of 425 MW capacity. It serves agriculture, food, pharma, municipal water, mining, construction, infrastructure, health, chemical, oil and gas, textile, animal feed, machinery, engineering, and consumer goods end markets. The company was founded in 1919 and is headquartered in Brussels, Belgium.
help-icon Live chat